Japan to undertake iPS cell trials in coming years

06/25/2009 | Breitbart.com

Japan reportedly is planning within five years to conduct clinical trials on induced pluripotent stem cells aimed at producing retinal pigment epithelial cells to cure age-related macular degeneration and hematopoietic stem cells to treat blood conditions, among other treatments. The plan also calls for the creation of an iPS cell bank within two years.

View Full Article in:

Breitbart.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC